Skip to content
March 30, 2026

Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519

You are about to leave MPM BioImpact's website. MPM BioImpact is not responsible for the content on other companies' websites.

Cancel Continue